Topic: Thyroid Cancer

A viral video from a "TikTok Doctor" claims that weight-loss drugs like Ozempic are derived from Gila monster venom and carry risks of thyroid cancer and paralyzed stomachs. While the drug uses a synthetic peptide, reports of gastroparesis have led to increased scrutiny of pharmaceutical marketing.

ABC News medical correspondent Dr. Jen Ashton discussed the safety profile of GLP-1 drugs, noting they have been FDA-approved for type 2 diabetes for nearly 20 years. While the segment downplayed risks like pancreatitis and thyroid cancer as rare, critics pointed out that a 1% risk rate is significant when applied to millions of users. The discussion highlighted the lack of long-term human studies on the effects of these drugs when used specifically for weight loss in non-diabetic populations.

An examination of the FDA's use of the term "chronic weight management" for Zepbound. The drug's safety warnings include the risk of thyroid C-cell tumors observed in rat studies, though the implications for human health remain officially unknown.

Pharmaceutical companies are racing to gain FDA approval for a pill version of the weight-loss drug Ozempic. While media reports frame the pill as a "game-changer" for those who are needle-phobic, the hosts highlight severe warnings in the product's packaging insert. Specifically, studies in rodents showed that semaglutide can cause thyroid tumors and medullary thyroid carcinoma, risks often downplayed in televised medical segments.

Direct-to-consumer advertising is dominated by skin condition treatments and weight-loss drugs like Ozempic. The EU has raised safety signals regarding GLP-1 medications and potential thyroid or pancreatic cancer risks. The Cleveland Clinic is reportedly running "damage control" segments to frame Ozempic's side effects, such as persistent vomiting, as manageable under a doctor's care.

The popularity of injectable weight loss drugs like Ozempic and Wegovy continues to grow, despite reports of significant gastrointestinal side effects. ABC's Becky Worley reported that while the drugs "quiet the food noise" in the brain, they carry risks of thyroid tumors in lab animals. The high cost and lack of insurance coverage remain major barriers for many users.

Dame Jennifer is promoted to Baroness for her ongoing support and her work on the "Animated No Agenda" project, which visualizes show segments. The hosts also acknowledge a joint knighthood and damehood for Bob and Kathy Appleby. A somber note includes a request for "F-cancer" karma for a producer's granddaughter battling thyroid cancer.

A Vice Media documentary on Fukushima is criticized for using "sweetened" audio and sensationalist claims about radiation levels. Nuclear expert Rod Adams provides a counter-analysis, stating that the levels of cesium and iodine released do not pose the long-term public health threat suggested by the film.